NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

NIH Research News


Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 105.

<< < 1 | 2 | 3 | 4 | 5 > >>

Public Release: 29-Apr-2014
American Academy of Neurology's 66th Annual Meeting
Preliminary results show improvement in MS symptoms
Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis, may improve symptoms in patients with the disorder, according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis. The findings were presented today by Rhonda Voskuhl, M.D., from the University of California, Los Angeles, at the American Academy of Neurology Annual Meeting in Philadelphia.
NIH/National Institute of Neurological Disorders and Stroke, National Multiple Sclerosis Society

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 29-Apr-2014
NIH center sets new goals for global health research and training
Global health research and training efforts should focus on combatting the growing epidemic of noncommunicable diseases, better incorporating information technology into research and training, and more effectively converting scientific discoveries into practice in low-resource settings, according to the Fogarty International Center's new strategic plan, released today. Fogarty is the component of the National Institutes of Health solely focused on supporting global health research and training, and coordinating international research partnerships across the agency.

Contact: Ann Puderbaugh
ann.puderbaugh@nih.gov
301-402-8614
NIH/Fogarty International Center

Public Release: 28-Apr-2014
Proceedings of the National Academy of Sciences
NIH scientists establish monkey model of hantavirus disease
National Institute of Allergy and Infectious Diseases researchers have developed an animal model of human hantavirus pulmonary syndrome in rhesus macaques, an advance that may lead to treatments, vaccines and improved methods of diagnosing the disease.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 28-Apr-2014
Proceedings of the National Academy of Sciences
Oxytocin promotes social behavior in infant rhesus monkeys
The hormone oxytocin appears to increase social behaviors in newborn rhesus monkeys, according to a study by researchers at the National Institutes of Health, the University of Parma in Italy, and the University of Massachusetts Amherst. The findings indicate that oxytocin is a promising candidate for new treatments for developmental disorders affecting social skills and bonding.
National Institutes of Health

Contact: Robert Bock or Katie Rush
bockr@mail.nih.gov
301-496-5134
NIH/National Institute of Child Health and Human Development

Public Release: 24-Apr-2014
New England Journal of Medicine
HHS leaders call for expanded use of medications to combat opioid overdose epidemic
A national response to the epidemic of prescription opioid overdose deaths was outlined yesterday in the New England Journal of Medicine by leaders of agencies in the US Department of Health and Human Services. The commentary calls upon health care providers to expand their use of medications to treat opioid addiction and reduce overdose deaths, and describes a number of misperceptions that have limited access to these potentially life-saving medications.
NIH/National Institute on Drug Abuse, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, Centers for Medicare and Medicaid Services

Contact: NIDA Press Team
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse

Public Release: 24-Apr-2014
Science
Channel makeover bioengineered to switch off neurons
Scientists have bioengineered an enhancement to a cutting edge technology that provides instant control over brain circuit activity with a flash of light. The research adds the same level of control over switching neurons off that, until now, had been limited to switching them on. What had been working through a weak pump now works through a highly responsive channel -- like going from a squirt to a gushing hose.
National Institutes of Health, NIH/National Institute of Mental Health, NIH/National Institute on Drug Abuse

Contact: Jules Asher
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health

Public Release: 23-Apr-2014
2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation
NIH scientist to receive Ross Prize in Molecular Medicine
John J. O'Shea, M.D., scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, has been named the 2014 recipient of the Ross Prize in Molecular Medicine, conferred by the Feinstein Institute's peer-reviewed, open-access journal Molecular Medicine. The award will be given on June 9 at the New York Academy of Sciences in Manhattan, followed by scientific presentations by Dr. O'Shea and other prominent researchers. NIAMS is part of the National Institutes of Health.

Contact: Trish Reynolds
reynoldsp2@mail.nih.gov
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Public Release: 22-Apr-2014
American Academy of Neurology's 66th Annual Meeting
JAMA
Glaucoma drug helps women with blinding disorder linked to obesity
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension, according to a study funded by the National Institutes of Health.
NIH/National Eye Institute

Contact: Daniel Stimson
neinews@nei.nih.gov
301-496-5248
NIH/National Eye Institute

Public Release: 17-Apr-2014
PLOS Pathogens
Study sheds light on how the immune system protects children from malaria
According to a study published today in PLOS Pathogens, children who live in regions of the world where malaria is common can mount an immune response to infection with malaria parasites that may enable them to avoid repeated bouts of high fever and illness and partially control the growth of malaria parasites in their bloodstream. The findings may help researchers develop future interventions that prevent or mitigate the disease caused by the malaria parasite.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 17-Apr-2014
Science
Jump-starting natural resilience reverses stress susceptibility
Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons and experimentally reversed it. Once electrical balance was restored, previously susceptible animals were no longer prone to becoming withdrawn, anxious, and listless following socially stressful experiences. But there's a twist. The secret to such resilience was not to suppress the runaway activity, but to push it up even further, eventually triggering a compensatory self-stabilizing response.
NIH/National Institute of Mental Health

Contact: Jules Asher
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health

Public Release: 16-Apr-2014
Neuron
Eavesdropping on brain cell chatter
Everything we do -- all of our movements, thoughts and feelings -- are the result of neurons talking with one another, and recent studies have suggested that some of the conversations might not be all that private. Brain cells known as astrocytes may be listening in on, or even participating in, some of those discussions. But a new mouse study suggests that astrocytes might only be tuning in part of the time -- specifically, when the neurons get really excited about something.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 15-Apr-2014
Cancer Research
Unexpected protein partnership has implications for cancer treatment
Scientists have identified two unlikely partners, in a type of immune cell called a macrophage, that work together, in response to cancer drugs, to increase inflammation in a way that may alter tumor growth. Researchers from the National Institutes of Health published the study in the journal Cancer Research.
NIH/National Institute of Environmental Health Sciences

Contact: Joe Balintfy
balintfyj@niehs.nih.gov
919-541-1993
NIH/National Institute of Environmental Health Sciences

Public Release: 10-Apr-2014
Cell
Too much protein may kill brain cells as Parkinson's progresses
Scientists may have discovered how the most common genetic cause of Parkinson's disease destroys brain cells and devastates many patients worldwide. The study was partially funded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke; the results may help scientists develop new therapies.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Christopher G. Thomas
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 9-Apr-2014
New England Journal of Medicine
Genetic defect may confer resistance to certain viral infections
A National Institutes of Health study reports that a rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Linda Huynh
linda.huynh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Apr-2014
Brain
Spinal stimulation helps 4 patients with paraplegia regain voluntary movement
Four people with paraplegia are able to voluntarily move previously paralyzed muscles as a result of a novel therapy that involves electrical stimulation of the spinal cord, according to a study funded in part by the National Institutes of Health and the Christopher & Dana Reeve Foundation. The participants, each of whom had been paralyzed for more than two years, were able to voluntarily flex their toes, ankles, and knees while the stimulator was active.
NIH/National Institute of Biomedical Imaging and Bioengineering

Contact: Margot Kern
nibibpress@mail.nih.gov
301-496-3500
NIH/National Institute of Biomedical Imaging & Bioengineering

Public Release: 3-Apr-2014
Science
HIV vaccine research must consider various immune responses
Future HIV vaccine research must consider both protective immune responses and those that might increase susceptibility to infection
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Apr-2014
Cell Metabolism
Obesity primes the colon for cancer, according to NIH study
Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United States.
NIH/National Institute of Environmental Health Sciences

Contact: Robin Arnette
arnetter@niehs.nih.gov
919-541-5143
NIH/National Institute of Environmental Health Sciences

Public Release: 26-Mar-2014
New England Journal of Medicine
Disorganized cortical patches suggest prenatal origin of autism
The architecture of the autistic brain is speckled with patches of abnormal neurons, according to research partially funded by the National Institute of Mental Health, part of the National Institutes of Health. Published in the New England Journal of Medicine on March 27, 2014, this study suggests that brain irregularities in children with autism can be traced back to prenatal development.
National Institutes of Health

Contact: Keri Chiodo
NIMHPress@nih.gov
301-443-4536
NIH/National Institute of Mental Health

Public Release: 20-Mar-2014
JAMA
Fauci: Robust research efforts needed to address challenge of antimicrobial resistance
Given the evolutionary ability of microbes to rapidly adapt, the threat of antimicrobial resistance likely will never be eliminated. Today, many factors compound the problem, including the inappropriate use of antibiotics and a dwindling supply of new medicines, leading to a global crisis of antimicrobial resistance.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 20-Mar-2014
PLOS Genetics
Researchers discover underlying genetics, marker for stroke, cardiovascular disease
Scientists studying the genomes of nearly 5,000 people have pinpointed a genetic variant tied to an increased risk for stroke, and have also uncovered new details about an important metabolic pathway that plays a major role in several common diseases. Together, their findings may provide new clues to underlying genetic and biochemical influences in the development of stroke and cardiovascular disease, and may also help lead to new treatment strategies.
NIH/National Human Genome Research Institute

Contact: Steven Benowitz
steven.benowitz@nih.gov
301-451-8325
NIH/National Human Genome Research Institute

Public Release: 19-Mar-2014
Science Translational Medicine
NIH grantees sharpen understanding of antibodies that may cut risk of HIV infection
What immune response should a vaccine elicit to prevent HIV infection? Two studies published online today bring scientists closer to answering this question by identifying previously unrecognized attributes of antibodies that appear to have reduced the risk of HIV infection in the only clinical trial to show efficacy, albeit modest, of an experimental vaccine regimen in people.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 19-Mar-2014
Clinical Infectious Diseases
Scientists describe gut bacteria that cause sepsis in preterm infants
Researchers studying intestinal bacteria in newborns have characterized the gut bacteria of premature infants who go on to develop sepsis, a serious and potentially life-threatening condition caused by bacteria in the bloodstream. Their findings suggest new strategies for the early detection and prevention of severe bloodstream infections.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 18-Mar-2014
International Symposium on Intensive Care and Emergency Medicine
New England Journal of Medicine
Sepsis study comparing 3 treatment methods shows same survival rate
A five-year, randomized clinical trial at 31 academic hospitals showed that survival of patients with septic shock was the same regardless of whether they received treatment based on specific protocols or the usual high-level of care. Sepsis affects more than 800,000 Americans annually, is the ninth leading cause of disease-related deaths and is the most expensive condition treated in US hospitals, costing more than $20 billion per year.
NIH/National Institute of General Medical Sciences

Contact: Alisa Zapp Machalek
alisa.machalek@nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences

Public Release: 17-Mar-2014
Proceedings of the National Academy of Sciences
NIH scientists track evolution of a superbug
Using genome sequencing, National Institutes of Health scientists and their colleagues have tracked the evolution of the antibiotic-resistant bacterium Klebsiella pneumoniae sequence type 258 (ST258), an important agent of hospital-acquired infections. While researchers had previously thought that ST258 K. pneumoniae strains spread from a single ancestor, the NIH team showed that the strains arose from at least two different lineages.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 11-Mar-2014
JAMA
Two surgeries for pelvic prolapse found similarly effective, safe
Two surgical treatments for a form of pelvic hernia affecting women have similar rates of success and safety, scientists in a National Institutes of Health research network have found. A guided exercise therapy to strengthen pelvic muscles did not add to the benefits of either surgery.
National Institutes of Health

Contact: Robert Bock
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development

Showing releases 76-100 out of 105.

<< < 1 | 2 | 3 | 4 | 5 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.